Drug intelligence / Profile preview

Yinhuang Jiaonang

Development stage: Unknown
Lead developer: Jilin Fukang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Yinhuang Jiaonang is a traditional Chinese medicine (TCM) oral capsule manufactured by Jilin Fukang Pharmaceutical. It is a standardized formulation composed of extracts from *Lonicera japonica* (Honeysuckle) and *Scutellaria baicalensis* (Baikal Skullcap). The primary active chemical markers in the formulation are chlorogenic acid and baicalin, which provide the drug with its characteristic anti-inflammatory, antibacterial, and antiviral properties. Clinically, it is used to clear heat and detoxify, and it is specifically indicated for the treatment of upper respiratory tract infections, acute tonsillitis, and pharyngitis.

Brand names: Yinhuang Jiaonang
Other names: Yinhuang CapsulesYinhuang Capsule

Targets

NF-κB

Beyond the preview

Go deeper on Yinhuang Jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinhuang Jiaonang.

Explore the full profile